{"id":"W2957828588","doi":"10.1038/s41416-019-0517-3","title":"Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; University of California, Los Angeles; University of Toronto; Princess Margaret Cancer Foundation; California Institute of Regenerative Medicine; California Institute for Regenerative Medicine","keywords":"Tolerability; Medicine; Dosing; Neutropenia; Pharmacokinetics; Cmax; Adverse effect; Pharmacodynamics; Response Evaluation Criteria in Solid Tumors; Internal medicine; Pharmacology; Clinical trial; Oncology; Phases of clinical research; Toxicity","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003155185,0.00009918085,0.0003439432,0.00005750904,0.00001991941,0.00001609289,0.00008363305,0.000122792,0.00002101954],"category_scores_gemma":[0.0001059472,0.0001136597,0.00007974377,0.0001139592,0.00004384774,0.00002058192,0.00003234089,0.0001915724,2.238032e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008671018,"about_ca_system_score_gemma":0.0002487889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001741986,"about_ca_topic_score_gemma":0.00468033,"domain_scores_codex":[0.9988721,0.00006937579,0.0005721211,0.0001946831,0.0001259328,0.0001657641],"domain_scores_gemma":[0.9993324,0.00002135376,0.0003251011,0.00008743194,0.0001803382,0.0000533644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06451619,0.001322341,0.05705097,0.0001684006,0.0001338688,0.00004513492,0.0003601498,0.003115838,0.765258,0.000009353188,0.0005229418,0.1074968],"study_design_scores_gemma":[0.2902884,0.008251916,0.3202775,0.002691273,0.0001331999,0.0005070551,0.0004463195,0.001599781,0.355167,0.000243805,0.01940713,0.0009865151],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99564,0.003453661,0.00007796269,0.00007448916,0.0002344146,0.000372552,0.00005859694,0.000001216092,0.00008715623],"genre_scores_gemma":[0.9960418,0.003501063,0.0001282667,0.00004693299,0.0002035772,0.000009356315,0.00001292793,0.0000117665,0.00004432815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.410091,"threshold_uncertainty_score":0.4634907,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004839703614920863,"score_gpt":0.2729538451451549,"score_spread":0.268114141530234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}